ReviewFrontiers in immunology2018

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Maarten Versteven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.